ONLINE DATABASE SEARCH - HIV-LS-297-MEMO
1. 43458 HIV-LS-297; PUBMED-HIV-6/02/2004
A Peptidomimetic HIV-Entry Inhibitor Directed against the CD4 Binding Site of the Viral Glycoprotein gp120
Neffe, AT and Meyer, B
Angew Chem Int Ed Engl 2004. 43(22): 2937-2940
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15170309&dopt=abstract
2. 43459 HIV-LS-297; PUBMED-HIV-6/02/2004
Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein
Han, Z, Simpson, JT, Fivash, MJ, Fisher, R, and Mori, T
Peptides 2004. 25(4): 551-61
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15165709&dopt=abstract
3. 43460 HIV-LS-297; PUBMED-HIV-6/02/2004
Isolation, Structure, Absolute Stereochemistry, and HIV-1 Integrase Inhibitory Activity of Integrasone, a Novel Fungal Polyketide
Herath, KB, Jayasuriya, H, Bills, GF, Polishook, JD, Dombrowski, AW, Guan, Z, Felock, PJ, Hazuda, DJ, and Singh, SB
J Nat Prod 2004. 67(5): 872-874
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15165153&dopt=abstract
4. 43461 HIV-LS-297; PUBMED-HIV-6/02/2004
Nef Stimulates Human Immunodeficiency Virus Type 1 Replication in Primary T Cells by Enhancing Virion-Associated gp120 Levels: Coreceptor-Dependent Requirement for Nef in Viral Replication
Lundquist, CA, Zhou, J, and Aiken, C
J Virol 2004. 78(12): 6287-96
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15163722&dopt=abstract
5. 43462 HIV-LS-297; PUBMED-HIV-6/02/2004
Design, Synthesis, Anti-HIV Activities, and Metabolic Stabilities of Alkenyldiarylmethane (ADAM) Non-nucleoside Reverse Transcriptase Inhibitors
Silvestri, MA, Nagarajan, M, De, Clercq E, Pannecouque, C, and Cushman, M
J Med Chem 2004. 47(12): 3149-62
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15163195&dopt=abstract
6. 43463 HIV-LS-297; PUBMED-HIV-6/02/2004
Anti-HIV Activity and Conformational Studies of Peptides Derived from the C-Terminal Sequence of SDF-1
Dettin, M, Pasquato, A, Scarinci, C, Zanchetta, M, De, Rossi A, and Di, Bello C
J Med Chem 2004. 47(12): 3058-64
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15163187&dopt=abstract
7. 43464 HIV-LS-297; SCIFINDER-HIV-5/25/2004
Quinolones with anti-HIV activity, and preparation thereof((IRM LLC, Bermuda)
He, Yun, Ellis, David Archer, Anaclerio, Beth Marie, Kuhen, Kelli L, Wu, Baogen, and Jiang, Tao
PATENT: WO 2004037853 A2; ISSUE DATE: 20040506
APPLICATION: 2003; PP: 71 pp.
8. 43465 HIV-LS-297; PUBMED-HIV-6/02/2004
The interaction between HIV-1 Gag and APOBEC3G
Cen, S, Guo, F, Niu, M, Saadatmand, J, Deflassieux, J, and Kleiman, L
J Biol Chem 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15159405&dopt=abstract
9. 43466 HIV-LS-297; PUBMED-HIV-6/02/2004
Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages
Ewart, GD, Nasr, N, Naif, H, Cox, GB, Cunningham, AL, and Gage, PW
Antimicrob Agents Chemother 2004. 48(6): 2325-30
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15155246&dopt=abstract
10. 43467 HIV-LS-297; SCIFINDER-HIV-5/25/2004
Non-nucleoside reverse transcriptase inhibitors for use in treatment of HIV infection((Ribapharm Inc., USA)
Girardet, Jean-Luc, Zhang, Zhijun, Hamatake, Robert, de la Rosa Hernandez, Martha A, Gunic, Esmir, Hong, Zhi, Kim, Hongwoo, Koh, Yung-Hyo, Nilar, Shahul, Shaw, Stephanie, and Yao, Nanhua
PATENT: WO 2004030611 A2; ISSUE DATE: 20040415
APPLICATION: 2003; PP: 70 pp.
11. 43468 HIV-LS-297; PUBMED-HIV-6/02/2004
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
Wiegand, HL, Doehle, BP, Bogerd, HP, and Cullen, BR
EMBO J 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15152192&dopt=abstract
12. 43469 HIV-LS-297; PUBMED-HIV-6/02/2004
Anti-AIDS agents. Part 58: Synthesis and anti-HIV activity of 1-thia-di-O-( [Formula: see text] )-camphanoyl-( [Formula: see text] )-cis-khellactone (1-thia-DCK) analogues
Xia, P, Yin, ZJ, Chen, Y, Zhang, Q, Zhang, B, Xia, Y, Yang, ZY, Kilgore, N, Wild, C, Morris-Natschke, SL, and Lee, KH
Bioorg Med Chem Lett 2004. 14(12): 3341-3
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15149703&dopt=abstract
13. 43470 HIV-LS-297; SCIFINDER-HIV-5/25/2004
Human immunodeficiency virus 1 integrase interacting protein Inip76 (hepatoma-derived growth factor), and diagnostic and therapeutic use for viral infection((K.U. Leuven Research and Development, Belg.)
Debyser, Zeger, Cherepanov, Peter, and De Clercq, Erik
PATENT: WO 2004029246 A2; ISSUE DATE: 20040408
APPLICATION: 2003; PP: 101 pp.
14. 43471 HIV-LS-297; PUBMED-HIV-6/02/2004
5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series
He, Y, Chen, F, Sun, G, Wang, Y, De, Clercq E, Balzarini, J, and Pannecouque, C
Bioorg Med Chem Lett 2004. 14(12): 3173-6
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15149669&dopt=abstract
15. 43472 HIV-LS-297; SCIFINDER-HIV-5/25/2004
Preparation of monoacylated betulin and dihydrobetulin derivatives for their therapeutic use as anti-HIV agents ((Panacos Pharmaceuticals, Inc. USA, Niigata University of Pharmacy and Applied Science, and The University of North Carolina At Chapel Hill))
Allaway, Graham P, Wild, Carl T, Kashiwada, Yoshiki, and Lee, Kuo-hsiung
PATENT: WO 2004028455 A2; ISSUE DATE: 20040408
APPLICATION: 2003; PP: 37 pp.
16. 43473 HIV-LS-297; PUBMED-HIV-6/02/2004
Synthesis and biological evaluation of novel beta-carboline derivatives as Tat-TAR interaction inhibitors
Yu, X, Lin, W, Li, J, and Yang, M
Bioorg Med Chem Lett 2004. 14(12): 3127-30
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15149658&dopt=abstract
17. 43474 HIV-LS-297; SCIFINDER-HIV-5/25/2004
Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors
Auwerx, Joeri, Esnouf, Robert, De Clercq, Erik, and Balzarini, Jan
Molecular Pharmacology 2004. 65(1): 244-251
18. 43475 HIV-LS-297; SCIFINDER-HIV-5/25/2004
R and D project at the School of Engineering and architecture of Fribourg. Development of the synthesis of a novel anti-AIDS drug: NU 1320
Poffet, Martine and Bourgeois, Jean-Marc
Chimia 2004. 58(1-2): 62-64
19. 43476 HIV-LS-297; SCIFINDER-HIV-5/25/2004
Methods for using gold(III) complexes as antitumor and anti-HIV agents((The University of Hong Kong, Peop. Rep. China)
Che, Chiming
PATENT: WO 2004024146 A1; ISSUE DATE: 20040325
APPLICATION: 2003; PP: 80 pp.
20. 43477 HIV-LS-297; WOS-HIV-5/23/2004
HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host
Argyris, EG and Pomerantz, RJ
TRENDS MICROBIOL 2004. 12(4): 145-148
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221051600002
21. 43478 HIV-LS-297; SCIFINDER-HIV-5/25/2004
Anti-HIV agent ((Fuso Pharmaceutical Industries, Ltd. Japan)
Wakamiya, Nobutaka, Ohtani, Katsuki, Sakamoto, Takashi, Keshi, Hiroyuki, and Kishi, Yuichiro
PATENT: WO 2004002511 A1; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 44 pp.
22. 43479 HIV-LS-297; WOS-HIV-5/23/2004
Synthesis and evaluation of novel prodrugs of foscarnet and dideoxycytidine with a universal carrier compound comprising a chemiluminescent and a photochromic conjugate
Mills, R and Wu, GZ
J PHARM SCI-US 2004. 93(5): 1320-1336
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221039800023
23. 43480 HIV-LS-297; WOS-HIV-5/23/2004
Topological estimation of cytotoxic activity of some anti-HIV agents: HEPT analogues
Agrawal, VK, Mishra, K, Sharma, R, and Khadikar, PV
J CHEM SCI 2004. 116(2): 93-99
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221122800005
24. 43481 HIV-LS-297; SCIFINDER-HIV-5/25/2004
Profiles of prototype antiviral agents interfering with the initial stages of HIV infection
De Clercq, Erik
CONFERENCE: Drug Discovery Strategies and Methods 2004: 309-336
25. 43482 HIV-LS-297; SCIFINDER-HIV-5/25/2004
Fusion polypeptides of HIV-Nef mutants and truncated human LNGFR, and retroviral vectors encoding them, for cell transduction and targetable anti-HIV-1 gene therapy ((Molmed SpA, Italy)
Federico, Maurizio
PATENT: US 20040087537 A1; ISSUE DATE: 20040506
APPLICATION: 2003-62012; PP: 36 pp.
26. 43483 HIV-LS-297; SCIFINDER-HIV-5/25/2004
HIV-1 gp41-derived HR1 peptides modified to form stable trimers, and their use in therapy to inhibit transmission of human immunodeficiency virus((Trimeris, Inc. USA)
Delmedico, Mary K and Dwyer, John
PATENT: WO 2004029074 A2; ISSUE DATE: 20040408
APPLICATION: 2003; PP: 94 pp.
27. 43484 HIV-LS-297; SCIFINDER-HIV-5/25/2004
Preparation of 9H-imidazo[1,2-d]dipyrido[2,3-b:3',2'-f][1,4]diazepine derivatives as tetracyclic non-nucleoside reverse transcriptase inhibitors useful against wild type and double-mutation K103N/Y181C enzymes ((Boehringer Ingelheim (Canada) Ltd., Can.)
Yoakim, Christiane, O'Meara, Jeffrey, Simoneau, Bruno, Ogilvie, William W, and Deziel, Robert
PATENT: WO 2004026875 A1; ISSUE DATE: 20040401
APPLICATION: 2003; PP: 54 pp.
28. 43485 HIV-LS-297; WOS-HIV-5/23/2004
Molecular dynamics simulation on the complex of HIV-1 integrase and the inhibitor aurintricarboxylic acid
Zhu, HM, Chen, WZ, and Wang, CX
ACTA CHIM SINICA 2004. 62(8): 745-749
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221044800001
29. 43486 HIV-LS-297; WOS-HIV-5/30/2004
A genomic selection strategy to identify accessible and dimerization blocking targets in the 5 '-UTR of HIV-1 RNA
Jakobsen, MR, Damgaard, CK, Andersen, ES, Podhajska, A, and Kjems, J
NUCLEIC ACIDS RES 2004. 32(7): art. no.-e67
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221145400033
30. 43487 HIV-LS-297; WOS-HIV-5/30/2004
Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein
Stojanova, A, Caro, C, Jarjour, RJV, Oster, SK, Penn, LZ, and Germinario, RJ
J CELL BIOCHEM 2004. 92(2): 400-413
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221154600016
31. 43488 HIV-LS-297; WOS-HIV-5/30/2004
HIV co-receptors as targets for antiviral therapy
Schols, D
CURR TOP MED CHEM 2004. 4(9): 883-893
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221176500003
32. 43489 HIV-LS-297; WOS-HIV-5/30/2004
TSAO compounds: The comprehensive story of a unique family of HIV-1 specific inhibitors of reverse transcriptase
Camarasa, MJ, San-Felix, A, Velazquez, S, Perez-Perez, MJ, Gago, F, and Balzarini, J
CURR TOP MED CHEM 2004. 4(9): 945-963
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221176500006
33. 43490 HIV-LS-297; WOS-HIV-5/30/2004
HIV protease inhibition: Limited recent progress and advances in understanding current pitfalls
Rodriguez-Barrios, F and Gago, F
CURR TOP MED CHEM 2004. 4(9): 991-1007
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221176500009
34. 43491 HIV-LS-297; WOS-HIV-5/30/2004
2 ',3 '-Didehydro-2 ',3 '-dideoxynucleosides are degraded to furfuryl alcohol under acidic conditions
Shi, JX, Ray, AS, Mathew, JS, Anderson, KS, Chu, CK, and Schinazi, RF
BIOORG MED CHEM LETT 2004. 14(9): 2159-2162
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221160200029
35. 43492 HIV-LS-297; WOS-HIV-5/30/2004
Inhibition of human immunodeficiency virus type 1 Tat-trans-activation-responsive region interaction by an antiviral quinolone derivative
Richter, S, Parolin, C, Gatto, B, Del, Vecchio C, Brocca-Cofano, E, Fravolini, A, Palu, G, and Palumbo, M
ANTIMICROB AGENTS CH 2004. 48(5): 1895-1899
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221227900065